5, 2019 (HealthDay News) -- Women with premature ovarian insufficiency
(POI) receiving hormone therapy have poor sleep quality, according to a study published online July 8 in Menopause.
[USA], July 16 (ANI): Women with premature ovarian insufficiency
(POI) who are receiving hormone therapy have poorer sleep quality and greater fatigue than women of the same age with preserved ovarian function, suggests a new study.
(32) showed that BMSCs were able to repair mouse ovarian insufficiency
following CTX induction.
Therefore, in our case report, we present a patient with premature ovarian insufficiency
(POI) because of refractory anemia and allogeneic stem cell transplantation, which seriously impaired her quality of life (QoL).
As the time passed, it was cleared that, laparoscopic surgery is not the final solution for all endometriosis patients, and even worse, in some cases induces premature ovarian insufficiency
and/or poor response to ART techniques.
Possiblerole of autoimmunity in patients with premature ovarian insufficiency
. Int J Fertil Steril 2014;7:281-290.
Premature ovarian insufficiency
(loss of ovarian function in women younger than age 40), should be considered in women with secondary amenorrhea of 4 months or longer.
The human papillomavirus vaccine does not appear to be associated with an increased risk of ovarian insufficiency
, according to researchers.
Maki and her associates cited studies that showed women who underwent surgical menopause in the form of hysterectomy with and without oophorectomy and women with ovarian insufficiency
also showed an elevated rate of depression.
A simple blood test ordered by a doctor, the Fertilome test can empower women to be more proactive about their family building by revealing whether they have genetic markers that have been associated with fertility-affecting conditions such as recurrent pregnancy loss, primary ovarian insufficiency
, endometriosis, and polycystic ovary syndrome.
Previous studies reported that melatonin ensures a protective effect on premature ovarian insufficiency
in ovarian and increasing ovarian follicles, decreasing follicular atresia [20-22].
In March 2018, the company announced preliminary blinded data for its Phase 1 trial of OvaPrime for women with primary ovarian insufficiency
and poor ovarian response.